Biologics Market Transparency Act of 2022
This bill requires biologics manufacturers to notify the Food and Drug Administration in advance of withdrawing a product from sale.
| Action Date | Type | Text | Source |
|---|---|---|---|
| 2022-05-25 | IntroReferral | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2709) | Senate |
| 2022-05-25 | IntroReferral | Introduced in Senate | Library of Congress |